There may be a role for addition of rivaroxaban to aspirin in patients with stable coronary artery disease.
Amitava BanerjeePublished in: BMJ evidence-based medicine (2018)
Keyphrases
- coronary artery disease
- cardiovascular events
- low dose
- venous thromboembolism
- atrial fibrillation
- percutaneous coronary intervention
- pulmonary embolism
- antiplatelet therapy
- coronary artery bypass grafting
- cardiovascular disease
- type diabetes
- acute coronary syndrome
- left ventricular
- anti inflammatory drugs
- aortic valve
- ejection fraction